Identity registry
Aliases, forms, and commonly conflated compounds resolve without erasing material distinctions.
PEPLYST STRUCTURED DATA · 2026.08.12A structured record
A structured record
that remembers change.
Each compound keeps its aliases and forms, source-linked claims, evidence boundaries, regulatory status, and dated conclusion history.
ATTENTION AND EVIDENCE
Where attention has moved ahead of human evidence.
The Promise–Proof Gap is not a treatment score. It compares a disclosed attention band with the depth of verified human evidence in Peplyst's reviewed sources.
AttentionAn editorial starting point that will be replaced by first-party behavior after minimum sample thresholds.Human evidenceOnly study-level evidence in people raises this band. Mechanistic and animal findings remain separate.Rate of changeThis signal moves only after a verified change in human evidence.
CompoundAttentionHuman proofPromise–proof gapEvidence velocity
TB-500Recovery & repair
HighNo identified human exposureVery wideQuietBPC-157Recovery & repair
BreakoutLimited human evidenceWideMonitoringMOTS-cMetabolic & longevity
RisingNo identified human exposureWideQuietGHK-CuSkin & appearance
HighLimited human evidenceWideBaseline pendingDihexa acetateBrain & sleep
RisingNo identified human exposureWideBaseline pendingMelanotan IISkin & appearance
HighHuman safety reports onlyWideBaseline pendingCJC-1295Metabolic & longevity
HighLimited human evidenceWideMonitoringIpamorelin acetateMetabolic & longevity
HighLimited human evidenceWideMonitoringKPVImmune & inflammation
EmergingNo identified human exposureWideQuietEpitalonMetabolic & longevity
RisingLimited human evidenceWideMonitoringSemaxBrain & sleep
RisingLimited human evidenceWideMonitoringLL-37Immune & inflammation
EmergingAssessment pendingNot yet ratedBaseline pendingPEG-MGFRecovery & repair
EmergingNo identified human exposureWideBaseline pendingAOD-9604Metabolic & longevity
HighMultiple human trialsWideMonitoringSelank acetateBrain & sleep
RisingLimited human evidenceWideMonitoringThymosin alpha-1Immune & inflammation
HighMultiple human trialsWideMonitoringEmideltide / DSIPBrain & sleep
EmergingLimited human evidenceMaterialMonitoringWHAT PEPLYST OWNS
Method PPG-1.0The transformations, not the public inputs.
Claim ledger
70 propositions preserve identity, use, evidence boundary, conclusion, source, confidence, and effective date.
Evidence deltas
ED-0.9 preserves 46 before-and-after records plus explicit conclusion-impact assessments.
Precedent graph
RPG-0.6 links 5 controlled comparison clusters while preserving transfer limits.
Study registry
PubMed IDs and NCT records normalize into stable study identities with deterministic compound links and an explicit review state.
Answer benchmark
Version PB-0.3 uses 140 source-linked questions to test identity, evidence, approval, advisory, and final-action distinctions.
Publication memory
Source approval, revision drafting, publication approval, and the public version write are separate attributable records.
Citation layer
Stable source IDs, snapshot hashes, derived-record edges, and bibliography formats make provenance portable without copying source bodies.
Reliability register
Vendor-neutral model outputs normalize into versioned, reproducible benchmark runs with public aggregate reporting.